Arkolith/Insider Trading/SPRO/Form 4

Shukla Sath

CEO and PresidentSpero Therapeutics, Inc. (SPRO) · full profile →Form 4 · filed Aug 6, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$43K
Net Open-Market Flow
-$43K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 5, 2024Sell(S)18K$1.31$23K1.1M
Aug 2, 2024Sell(S)15K$1.32$20K1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-092170) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML